TIMP3 and liver dysplastic nodule: Here, we provide evidence that treatment with exogenous peptides, derived from the fusion of the N‐terminal domain of human TIMP3 protein with G3C12 galectin‐3 targeting peptide, may delay development of DN in DBA/2J diabetic mice.